Table 3.
Baseline parameters of testosterone therapy and control blood donors for post-transfusion recovery study in immunodeficient mice.
| TT (N=21) | Controls (N=20) | p (t-test) | |||
|---|---|---|---|---|---|
| Age (years) | 50.5±10.3 | 52.2±12.2 | 0.638 | ||
| Sex | Males N=19 | Females N=2 | Males N=18 | Females N=2 | |
| Hemoglobin (g/dL) at donation | 17.2±1.6 | 16.2±1.9 | 0.068 | ||
| BMI (Kg/m2) | 29.9±3.7 | 27.2±3.5 | 0.023 | ||
| Blood group: A,B,O,AB | N= 7,3,10,1 | N= 6,3,10,1 | |||
| Ethnicity: White, African American, Asian American, NA | N=17,1,1,2 | N=17/1/1/1 | |||
| Free testosterone (pg/mL) | 266.3±309.3 | 97.5±101.9 | 0.034 | ||
| Total testosterone (ng/dL) | 802.4.±697.1 | 459.4±317 | 0.063 | ||
TT, testosterone therapy. BMI, body mass index. Free testosterone, normal range 47–244 pg/mL. Total testosterone, normal range 300–890 ng/dL. NA, not available